CATT trial

GPTKB entity

Statements (62)
Predicate Object
gptkbp:instance_of gptkb:legal_case
gptkbp:bfsLayer 4
gptkbp:bfsParent gptkb:Lucentis
gptkbp:collaborated_with pharmaceutical companies
gptkbp:collaborations multi-center study
gptkbp:completed gptkb:2011
gptkbp:conducted gptkb:United_States
research institutions
patient consent
gptkbp:events long-term outcomes
gptkbp:focuses_on gptkb:psychologist
gptkbp:has_impact_on treatment guidelines for AMD
https://www.w3.org/2000/01/rdf-schema#label CATT trial
gptkbp:influences clinical practice
gptkbp:involves multiple sites
randomized controlled trial
gptkbp:is_analyzed_in treatment efficacy
cost-effectiveness
adverse effects
meta-analyses
gptkbp:is_associated_with improved vision outcomes
gptkbp:is_cited_in clinical research
subsequent studies
gptkbp:is_compared_to anti-VEGF treatments
gptkbp:is_discussed_in gptkb:hospital
medical conferences
patient forums
gptkbp:is_documented_in research publications
clinical trial registries
gptkbp:is_evaluated_by peer review
patient outcomes
clinical assessments
gptkbp:is_influenced_by regulatory agencies
gptkbp:is_linked_to gptkb:legislation
treatment advancements
gptkbp:is_part_of evidence-based medicine
clinical trial registries
clinical research networks
AMD research initiatives
gptkbp:is_referenced_in gptkb:academic_journal
clinical discussions
gptkbp:is_related_to retinal diseases
VEGF inhibitors
gptkbp:is_reviewed_by systematic reviews
gptkbp:is_supported_by grants
patient advocacy groups
clinical trial networks
gptkbp:is_utilized_in clinical trials
ophthalmologists
gptkbp:launched gptkb:2008
gptkbp:measures visual acuity
gptkbp:outcome safety and efficacy
gptkbp:participants patients with wet AMD
gptkbp:published_by gptkb:sneaker
gptkbp:receives_funding_from gptkb:NIH
gptkbp:reports_to gptkb:municipality
social media
gptkbp:result gptkb:New_England_Journal_of_Medicine
gptkbp:significance ophthalmology research
gptkbp:sponsor gptkb:National_Eye_Institute
gptkbp:uses gptkb:Avastin
gptkb:Lucentis